Bristol-Myers Squibb | BMY - Pre Tax Profit

Stock Price
58.83
Daily Change
-1.76 -2.90%
Monthly
-1.29%
Yearly
16.33%
Q2 Forecast
57.45

Bristol-Myers Squibb reported $1.47B in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Abbott USD 2.39B 27M Mar/2026
ALKERMES USD 100.74M 4.1M Sep/2025
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Biogen USD 377.7M 433.7M Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Merck USD 3.42B 3.32B Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sanofi EUR -1.16B 6.23B Dec/2025
United Therapeutics USD 444M 6M Dec/2025
Zoetis USD 887M 15M Sep/2025